Condition: Chronic fatigue syndrome
Author: Olli Polo
Date: Nov 2019
A report on the safety and effectiveness data accumulated in clinical practice when treating ME/CFS with low dose naltrexone. The high frequency of treatment response and good safety profile observed could prompt prospective controlled studies to confirm the feasibility of LDN in alleviating ME/CFS symptoms.